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1. Introduction 
1.1 Extent of disease 
Cardiovascular atherosclerosis is the most common disease in the industrial countries. In the 
United States of America more than 1 million patients every year are admitted to the 
coronary care unit with suspected acute myocardial infarction (Yusuf et al, 2004; American 
Heart Association, 2007). The incidence of acute myocardial infarction in USA is 865000, 
565000 of them new infarctions annually. In Europe, the situation is similar to the USA, 
however in northern countries the incidence is higher than in southern countries (Lopez et 
al, 2006). In the emerging market economies in Eastern Europe, higher cardiovascular 
mortality is found. The burden of cardiovascular and coronary heart disease in developing 
countries is approaching that in developed countries. Thus the problem is a worldwide 
problem and international joint efforts are needed in order to treat this still prevalent 
disease.  
Mortality of acute myocardial infarction is decreasing steadily. This decrease is related to 
reduction in the prevalence of disease in some countries, improvement of primary 
prevention and secondary prevention as well as treatment of the acute event (Hunink et al, 
1997; Cooper et al, 2000).   
1.2 Contemporary treatment 
Primary percutaneous coronary intervention (PCI) is the treatment of choice in acute ST 
elevation myocardial infarction (Grines et al, 1993; Zijlstra et al, 1993; GUSTO, 1997; De 
Luca et al, 2004).The objective of primary PCI is to restore myocardial perfusion in the 
coronary bed distal to the occluded culprit artery. The TIMI classification (Chesebro et al, 
1987) and myocardial blush grades (van't Hof, 1998; Gibson et al, 2000; Stone et al, 2002) 
used to assess epicardial coronary artery flow and myocardial perfusion after primary PCI 
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predict outcome after the procedure. However, the TIMI flow and myocardial blush 
grades are semi-quantitative, invasive, not easily repeatable, and do not reflect 
subsequent events and processes at the level of the coronary artery and microcirculation. 
Thus, even with successful primary PCI and the high rate of patency of the culprit artery, 
left ventricular functional recovery is limited and not well predicted (Stone et al, 1997; 
Zijlstra et al, 1997).  
1.3 Limitations and problems of contemporary treatment 
The main goal of primary PCI is to open the occluded epicardial coronary artery, and thus 
to re-establish blood flow to the jeopardized myocardium. In order to nourish the 
myocardium, blood must flow through the epicardial coronary artery segments, resistance 
vessels, arterioles and capillaries before reaching venules and veins. The epicardial coronary 
arteries are larger than 400 um, serve as conduit vessels and their diameter is regulated by 
shear stress and do not contribute significantly to pressure drop. Coronary resistance vessels 
with diameter between 100 and 400 um are affected myogenically mainly by shear stress 
and luminal pressure. Resistance coronary vessels with diameter less than 100um are 
sensitive to local tissue metabolism and directly control perfusion to the low pressure 
capillary bed nourishing the myocardium. Myocardial capillary density is 3500/mm2 with 
inter-capillary distance of 17 um , greater in the subendocardium than in the subepicardium 
(Canty, 2008).  
Microvascular injury is the leading cause for the decreased myocardial perfusion 
observed in about 80% of patients after successful PCI (Gibson et al, 2000; Stone et al, 
1997; Zijlstra et al, 1997; Kondo et al, 1998). Various factors contribute to the limited 
myocardial perfusion, including micro-emboli, platelets, white blood cells, ischemic 
necrosis, and reperfusion injury(Chesebro et al, 1987; van't Hof, 1998; Gibson et al, 2000; 
Stone et al, 2002).  
1.4 Detection of dysfunction of the microcirculation 
As already mentioned, myocardial blush grade as assessed in the catheterization laboratory 
evaluates the function of the microcirculation.  
Extent of resolution of ST-segment elevation after primary angioplasty is an adequate 
indicator of the function of the microcirculation and myocardial perfusion. 
Measurement of coronary flow velocities using Doppler wire and pressure recordings to 
assess severity of coronary artery stenoses are invasive procedures in addition to other 
disadvantages (Iliceto et al 1991; Erbel et al, 1991; Kozakova et al, 1994; Donohue et al, 1993; 
Miller et al, 1994; Di Carli et al, 1995). 
Trans-esophageal echocardiography visualizes only the proximal coronary arteries and 
Doppler sampling is feasible in less than 70% of patients (Joye et al, 1994; Kern et al 1995; 
Abizaid et al, 1998). 
Recent technologic advances in trans-thoracic echocardiography made Doppler sampling of 
coronary artery velocities possible (Voci et al, 1998; Caiati et al, 1999; Hildick-Smith et al, 
2000; Higashiue et al, 2001; Pizzuto et al, 2001; Takeuchi et al, 2001). Contrast agents may 
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enhance the detection rate of coronary velocities (Abizaid et al, 1998; Caiati et al, 1999), 
however, an experienced operator is essential. 
Sampling of blood velocities in the left anterior descending coronary artery is successful 
almost in all patients. The advantages of Doppler sampling of coronary artery blood 
velocities is that it is non-invasive and can be repeated easily in the coronary care unit. As 
we demonstrated recently using transthoracic Doppler, the function of the microcirculation 
is dynamic and changes after primary angioplasty (Sharif et al, 2008; 2010). After primary 
coronary intervention in acute myocardial infraction the microcircirculation may improve or 
deteriorate. Therefore, transthoracic Doppler sampling of coronary artery velocities is even 
more important than other methods for the evaluation of the function of coronary 
microcirculation.   
1.5 Possible solution for coronary microvascular dysfunction 
After having the epicardial coronary artery treated and well open, according to the 
mechanisms of microcirculatory dysfunction, platelet micro-emboli and changes in platelet 
activity may have an impact on myocardial perfusion. Therefore, in the present study we 
examine the effects adjuvant treatment with glycoprotein 2b3a receptor blockers on the 
function of the microcirculation after primary angioplasty in the setting of acute anterior ST-
elevation myocardial infarction. 
2. Methods 
Forty five consecutive patients with acute ST elevation anterior myocardial infarction 
undergoing primary PCI were enrolled in the study. All fulfilled the following criteria: 1) 
First anterior wall ST segment elevation myocardial infarction (STEMI). 2) Primary PCI 
within 12 hours of the onset of symptoms. 3) Routine informed consent to perform primary 
PCI. Anterior STEMI was defined as continuous chest pain for at least 30 minutes and ST 
elevation of at least 2.0mm in ≥2 contiguous precordial ECG leads. Exclusion criteria 
included one of the following clinical or angiographic findings: Prior bypass surgery, 
previous anterior STEMI, significant left main artery disease, failed primary PCI. 
2.1 Primary PCI 
Primary PCI was performed in standard fashion. All subjects were treated with oral 
clopidogral (600 mg) and aspirin (300 mg) in the emergency department. Thirty one patients 
were treated with an intravenous bolus injection of heparin (50-70 U/Kg) to achieve 
coagulation time of ≥ 250msec, Fourteen patients were treated before angioplasty with 
intravenous eptifibatide as 2 boluses of 180ug/kg, ten minutes apart, and a maintenance 
infusion at a rate of 2ug/kg/min for 24 hours, and 500 units heparin/hour. Coronary 
angiography and primary PCI were performed subsequently. Bare metal stents were 
deployed by high-pressure implantation techniques. Low magnification angiogram at either 
the right 30 º or 90 º lateral projections with prolonged cine was performed to optimize 
myocardial blush grade (MBG) documentation at the end of the intervention as previously 
described ( van't Hof et al, 1998). All patients were treated with clopidogrel and aspirin for 
12 months after the procedure.  
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2.2 Echocardiography 
All patients had complete Doppler echcardiographic studies, within the first 6 hours after 
primary PCI, 48 hours later, and 5 days after the intervention. 
Siemens, Acuson Sequoia echocardiographic system, California, equipped with 3.5-7MHZ 
transducers was used. All patients had complete Doppler echcardiographic studies, within 
the first 6 hours after primary PCI, 48 hours after primary PCI, and 5 days after primary 
PCI. 
In order to obtain LAD flows, the color Doppler Nyquist limit was set at 17 cm/sec or 
power Doppler modality was applied. Systematic attempt to get LAD-color flow were 
performed. From low parasternal short axis view, search for diastolic color flow in the 
anterior interventricular groove followed by clockwise rotation was performed, while form 
apical foreshortened two chamber views LAD diastolic flow was located in the 
interventricular groove and the counterclockwise rotation of the transducer was performed. 
Colour Doppler sampling was easy to achieve, branches could be seen (figure 1) and 
margins of colour jet well delineated allowing measurement of jet width (figure 2).  
 
Fig. 1. Colour Doppler of the LAD and diagonal branch 
 
Fig. 2. Colour Doppler of the LAD allowing measurement of jet width 
Pulsed-wave Doppler sampling was consistent (figure 3), with dominant diastolic 
component and clear envelope easy to trace (figure 4) and well demonstrated systolic 
component (figure 5). 
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Fig. 3. Consistent pulsed-wave Doppler sampling of LAD blood velocity  
 
 
 
Fig. 4. Pulsed-wave Doppler of LAD blood velocity with dominant, easy to trace diastolic 
component 
 
 
Fig. 5. Pulsed-wave Doppler of LAD blood velocity with prominent systolic flow 
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2.3 Echocardiographic measurements 
Chamber diameters and usual measurements were performed according to 
recommendations of American Society of Echocardiography. Ejection fraction of LV (LVEF) 
was measured from biplane apical views. 
For the calculation of wall motion score index  
 
16
16
score of segments
LV WMSI    (1) 
assigning a value of 1 for normal LV wall motion, 2 for hypokinesis and 3 for akinesis. Using 
the same values of wall motion scores, LAD 9 segmental score index was calculated as: 
 
9
9
score of segments
LAD WMSI    (2) 
2.4 Velocity of the LAD and measurements 
In order to obtain LAD flows, the color Doppler Nyquist limit was set at 17 cm/sec. From 
low parasternal short axis view, search for diastolic color flow in the anterior 
interventricular groove followed by clockwise rotation was performed, while form apical 
foreshortened two chamber views LAD diastolic flow was located in the interventricular 
groove and the counterclockwise rotation of the transducer was performed. 
Parameters of LAD velocity patterns were averaged from 3 beats, all in sinus rhythm. 
Diastolic LAD deceleration Time (DDT) was measured as the time from peak diastolic 
velocity to the intercept of tangent of the velocity envelope with baseline. Pressure half time 
(P1/2T) (msec) was determined as the time for peak diastolic velocity to decrease to 1
2
 of 
its initial value. In addition, search for LAD early systolic flow reversal with early systolic 
negative velocity (ESFR) was performed. 
2.5 LAD Flow measurements 
Diameter of the jet of blood velocity through the LAD (D), heart rate (HR) and diastolic time 
velocity integral (TVIDiastole) of the pulsed-wave Doppler were used to calculate blood flow 
in the LAD according to the following formula (3):  
 
2
4
D
DaistoleDiastolic LAD Flow HR TVI    (3) 
2.6 Angiographic analysis 
Coronary angiograms were reviewed by two experienced interventional cardiologists. TIMI 
(thrombolysis in myocardial infarction) and MBG (myocardial blush grade) were evaluated 
pre and post- PCI. TIMI-0: no antigrade flow beyond the occlusion; TIMI-1: contrast passes 
through the occlusion but do not opacify the distality entirely; TIMI-2: contrast passes 
through the obstruction and opacify the distal coronary bed slower than normal or clears 
slower than normal; TIMI-3: prompt contrast opacification and clearance of the distal 
coronary bed (Chesebro et al, 1987). MBG was evaluated as: MBG-0: minimal or no 
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myocardial blush; MBG-1: myocardial staining persists on the next injection; MBG-2: 
myocardial staining with slow washout and persists markedly at the end of injection; MBG-
3: normal myocardial staining and clearance with only mild staining at end of injection 
(van't Hof, 1998; Gibson et al, 2000; Stone et al, 2002).  
2.7 Statistical analysis 
Statistical analyses wee conducted using SPSS software version 13. All values were 
expressed as means and standard deviations. Two-tailed student's-t test was performed to 
compare changes in DDT and P1/2T, considering p<0.05 as statistically significant. 
Assessment of clinical utility of flow parameters was done by calculating sensitivity, 
specificity, positive and negative predictive values as well as diagnostic accuracy. 
Correlation coefficients and their p value were calculated to evaluate the relation of LAD 
flow parameters with LV systolic function parameters pre-discharge (5 days after PCI). 
3. Results 
3.1 Angiographic results 
Average TIMI and myocardial blush grades (MBG) before angioplasty were not different 
between patient who were treated with epitifibatide compared to those in whom the 
medicine was not administrated (table 1). However, TIMI=0, was observed in 33% with 
eptifibatide compared to 55% in those without. In both groups TIMI and MBG grades 
improved after the PCI. TIMI grade after the intervention was higher in subjects who were 
treated with epifibatide, however, MBG was not different.  
 
 
TIMI Pre-
PPCI 
TIMI 
Post-
PPCI 
TIMI p-
(Pre/Post) 
MBG 
Pre-PPCI
MBG 
Post-
PPCI 
MBG p-
(Pre/Post) 
Diastolic 
LAD Flow 
(ml/min) 
EPT-Yes 1.07±1.07 2.43±0.5 0.0004 0.71±1.07 1.93±0.73 0.002 49±26 
EPT-NO 0.94±1.2 2.28±0.6 1.3×10-9  0.52±1.06 2.25±0.9 6×10-9  35±17 
P 
(Yes/No) 
0.7 0.049  0.57 0.22  0.09 
Table 1. Pre and Post PCI, TIMI and MBG and Diastolic LAD Flow 
3.2 Feasibility and examples of LAD Doppler velocity sampling 
Sampling of LAD blood velocities was possible at all occasions in all the patients. Colour-
Doppler jet of blood velocity through the LAD had distinct boarders and measurement of 
diameters was possible with inter and intra-observer variability of 0.1±0.05mm and 
0.15±0.07mm. Inter and intra-observer variability of LAD velocities were 2±0.4 and 1.5±0.2 
cm/sec and of time velocity integrals 0.4±0.1 and 0.3±0.1cm, and of pressure half time 10±3 
and 8±3 msec In figure 6, an example of a patient with acute anterior STEMI after primary 
angioplasty and bare metal stent implantation in the LAD. The velocity profile demonstrates 
prolonged diastolic deceleration time (more than 600msec) and forward systolic flow. In this 
patient left ventricular systolic function improved and left ventricular ejection fraction at 
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discharge was normal. In figure 7, an example of a patient with unfavorable LAD blood 
velocity profile after primary angioplasty and bare metal stent implantation in a patient 
with acute anterior STEMI. Short diastolic deceleration time (less than 600msec) and early 
systolic flow reversal are demonstrated. In this patient left ventricular ejection fraction was 
reduced at admission and did not improve later.  
 
 
Fig. 6. Favourable LAD blood velocity profile with prolonged diastolic deceleration time 
and forward systolic flow. 
 
 
Fig. 7. Unfavourable LAD blood velocity profile with reduced diastolic deceleration time 
and early systolic flow reversal. 
3.3 LAD velocity profiles 
Early systolic flow reversal did not occur with eptifibatide while it was noticed in 6 (17%) in 
those without, p<0.05 (table 2).  
 
 ESFR 
Early 
ESFR 
48 Hr. 
ESFR 
5 Days 
EPT-Yes 0 0 0 
EPT-No 6 4 2 
 
Table 2. LAD Systolic Flow Reversal  
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Diastolic deceleration time of LAD flow averaged 629±238 msec in patients treated with 
eptifibatide and 593±344 msec in those without, p=0.7 (figure 8). Short (<600msec) diastolic 
deceleration time occurred in 6 (40%) of those treated with eptifibatide, compared to 12 
(39%) in those not treated, p=ns (figure 8).  
 
Fig. 8. Histogram of diastolic deceleration time and pressure half time of LAD blood velocity 
profiles in patients with and those without eptifibatide treatment. 
Patients treated with eptifibatide had higher diastolic velocities, 39±11 cm/sec, vs 31±9 
cm/sec, p=0.043 and tended to have higher diastolic LAD flows, 49±26 ml/min, vs 35±17 
ml/min, p=0.09 (figure 9). 
 
Fig. 9. Histogram of diastolic and systolic velocities of LAD blood velocity profiles in 
patients with and those without eptifibatide treatment. 
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3.4 LAD Flow 
LAD flow tended to be higher early after primary angioplasty in subjects pre-treated with 
eptifibatide, however on the following evaluations during mid-hospital stay and pre-
discharge diastolic flow in the LAD was similar in both groups.  
 
Fig. 10. Histogram of diastolic flow in the LAD in patients with and those without 
eptifibatide treatment. 
3.5 Left ventricular systolic function 
LVEF with epifibatide at baseline 37±6.5% was similar to that in those without, 36.7±4.4%, 
and at discharge, with epifibatide 43.8±8.2% and in those without 45±8.9%, p=ns. 
 
 
LVEF (%) 
Early 
LVEF(%) 
5 Days 
LV-
WMSI 
early 
LV-WMSI 
5 Days 
LAD-
WMSI 
early  
LAD-
WMSI 
5 Days 
EPT-Yes 37±6.49 43.8±8.2 1.68±0.17 1.49±0.295 2.15±0.2 1.83±0.43 
EPT-NO 36.7±4.4 45±8.9 1.6±0.24  1.39±0.32 2±10.4 1.63±0.55 
P 
(Yes/No) 
0.79 0.687 0.296 0.282 0.165 0.258 
Table 3. LV Systolic Function 
4. Discussion 
4.1 Brief summary of results 
In this study, per-treatment of patients with acute anterior STEMI undergoing primary 
coronary angioplasty prevented severe dysfunction of the coronary microcirculation as 
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evidenced by absence of early systolic flow reversal in subjects treated with epitifibatide; 
however, less severe dysfunction of the microcirculation was not different between the 
groups since diastolic deceleration times by Doppler, and myocardial blush grades were 
similar. Moreover, diastolic maximal blood velocities early after PCI were higher in patients 
treated with eptifibatide but similar later on. Eptfibatide treatment was associated with a 
tendency of larger diastolic blood flow through the LAD but not later. All these changes 
with eptifibatide treatment did not affect left ventricular systolic function which was similar 
in both treatment groups, early after PCI and pre-discharge. 
4.2 Applicability of sampling of LAD blood velocities 
Transthoracic Doppler sampling of coronary blood velocities is not mentioned or not 
stressed sufficiently in most textbooks of echocardiography. Thus, the importance of this 
study is related not only to the treatment of patients with acute STEMI. We found that 
sampling of LAD blood velocities was possible in all the patients and at all occasions. We 
believe that sampling of LAD blood velocities should be applied widely and repeated when 
needed and in all echocardiographic studies. In fact, electrocardiographic recording is 
performed when patients have chest pain, and in a similar fashion, echocardiography and 
sampling of coronary blood velocity may be performed in such patients in coronary care 
units.  
4.3 Transthoracic Doppler sampling of LAD blood velocities and other methods 
Measurement of coronary flow velocities using Doppler wire and pressure recordings to 
assess severity of coronary artery and microcirculation are invasive procedures in addition 
to other disadvantage (Iliceto et al 1991; Erbel et al, 1991; Kozakova et al, 1994; Donohue et 
al, 1993; Miller et al, 1994; Di Carli et al, 1995). Normal peak diastolic velocities in the 
present study were similar to those reported previously by invasive Doppler flowires (Ofili 
et al, 1993). 
Trans-esophageal echocardiography visualizes only the proximal coronary arteries and 
Doppler sampling is feasible in less than 70% of patients (Joye et al, 1994; Kern et al 1995; 
Abizaid et al, 1998). Recent technologic advances in trans-thoracic echocardiography made 
Doppler sampling of coronary artery velocities possible (Voci et al, 1998; Caiati et al, 1999; 
Hildick-Smith et al, 2000; Higashiue et al, 2001; Pizzuto et al, 2001; Takeuchi et al, 2001). 
Contrast agents may enhance the detection rate of coronary velocities (Abizaid et al, 1998; 
Caiati et al, 1999), however, with increasing experience of the operator contrast agents are 
not needed. 
4.4 Validity of LAD blood velocities and flow calculations  
The range of the value of LAD blood velocities and time velocity integrals (Sharif et al, 2010) 
is similar to those found through cardiac valves with similar reproducibility and 
applicability. The diameter of the LAD and of the colour jet of blood flow through the vessel 
is in the range of diameter of vena contracta of regurgitant jets through cardiac valves. 
Moreover, LAD-colour jet diameter is similar to that of proximal iso-velocity surfaces of 
regurgitant jets through the mitral valve, so it can be applied in a similar fashion and 
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squared to calculate areas. Thus if blood velocities, and colour jet diameters of the LAD are 
similar to those of cardiac valves, then flow calculations should be of the same degree of 
validity.  
4.5 Need for coronary blood velocity sampling in acute STEMI 
Restoration of epicardial coronary artery flow by primary PCI in the setting of acute STEMI 
improves outcome (Shah et al, 2000), however optimization of myocardial tissue perfusion 
improves the prediction of outcome (van't Hof et al, 1998; Shah et al, 2000; van't Hof et al, 
1997; Claeys et al, 1999; The TIMI Study Group, 19985; Gibson et al, 1996; 1999; 2001; de 
Lemos, 2001; Dörge et al, 2000). Despite these findings, still even with successful primary 
PCI and the high rate of patency of the culprit artery, left ventricular functional recovery is 
limited and not well predicted (Stone et al, 1997; Zijlstra et al, 1997). 
 Despite the value of myocardial blush grade in the evaluation of myocardial perfusion it is 
not repeatable because of its invasive nature. Resolution of ST-elevation also correlates with 
better myocardial perfusion, however it reflects only the stage immediately following the 
emergency PCI. As we have shown (Sharif et al, 2008) the function of coronary 
microcirculation is variable and may improve or worsen during the hospital stay after 
primary coronary angioplasty in patients with acute STEMI. Therefore, Doppler 
transthorcaic sampling of LAD blood velocities is important in such patients.  
4.6 Diastolic deceleration time of LAD blood velocity curve (DDT) and the 
microcirculation 
To understand the relation between DDT and coronary microcirculation, consider normal 
subjects where the intra-myocardial blood capacitance vessels fill during diastole without 
significant increase in intramural pressure, therefore the DDT is prolonged. When the 
capacitance vessels are partially obstructed with miroemboli there is impedance to flow in 
diastole, therefore the DDT is abbreviated (Kawamoto et al, 1999; Yamamaro et al, 2002). 
When the blockage of the microcirculation is more severe, the milking of blood in systole 
cannot proceed to the venules; instead, it is pushed back into the coronary artery and results 
in early systolic flow reversal (Kawamoto et al, 1999; Yamamaro et al, 2002).  
4.7 Mechanisms of dysfunction of coronary microcirculation after primary coronary 
angioplasty 
After primary PCI, dysfunction of the microcirculation may develop as a result of 
periprocedural microembolization to the distal coronary artery bed. In addition, recently, 
evidence for the hypothesis that in situ inflammation and thrombosis contributes to 
dysfunction of the microcirculation after primary PCI was provided (Dörge et al, 2000). 
Despite the tendency of microemboli to dissolve after they developed during primary 
PCI, in situ microcirculatory thrombosis may account for worsening of microcirculatory 
function late after primary PCI. Thus not only early evaluation of the coronary 
microcirculation is important; in fact the worst coronary microcirculatory status like 
minimal diastolic deceleration time of LAD blood velocity seems to be even more 
important.  
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4.8 The logic and need for intense antiplatelet treatment in acute STEMI 
Plaque disruption is considered to be the common substrate of acute coronary syndromes 
(Boersma et al, 2003). Consequently, the blood is exposed to a significant quantity of 
thrombogenic materials initiating platelet aggregation and the lumen of the coronary artery 
become obstructed by a combination of platelets, fibrin and red blood cells. Moreover, as 
mentioned previously, primary coronary angioplasty in patients with acute STEMI is 
associated with microembilzation rich with platelets to the distal coronary circulation. 
Therefore, the administration of rapidly acting powerful antiplatelet agent seems logical. 
Glycoprotein IIbIIIa receptor blockers fulfil these requirements.  
4.9 The evidence of effectiveness of Glycoprotein IIbIIIa receptor blockers in acute 
STEMI 
Thus, Abciximab (Neumann et al, 1998) maintained patency of large coronary arteries, but 
in addition was associated with higher coronary artery peak blood velocities and better left 
ventricular wall motion score index and higher left ventricular ejection fraction compared to 
heparin. Abciximab (de Lemos et al, 2000) was shown to improve both epicardial coronary 
artery flow and myocardial reperfusion as evidenced by resolution of ST elevation in 
patients with acute STEMI. Eptifibatide and tirofiban- small molecule Glycoprotein IIbIIIa 
receptor blockers- in a meta-analysis study were shown to be non-inferior to abciximab in 
patients with acute STEMI undergoing PPCI (Ottani et al, 2010). Eptifibatide was shown to 
be equal to abciximab as an adjunct to PPCI in acute STEMI and as effective in causing 
resolution of ST elevation ( Zeymer et al, 2010) and reduced the rate one year mortality and 
re-infarction ( Akerblom et al, 2010). Eptifibatide improved clinical outcome in patients with 
STEMI undergoing PPCI (Mahmoudi et al, 2011). In our study eptifibatide prevented severe 
dysfunction of coronary microcirculation after PPCI in acute STEMI which was not 
translated into better left ventricular systolic function. A larger number of patients may 
reveal such benefit in recovering left ventricular systolic function.  
5. Summary and look to the future 
Thus, transthoracic Doppler echocardiography is feasible and provides important 
information about the function of coronary microcirculation in patients with acute STEMI 
undergoing PPCI. Treatment with eptifibatide before primary angioplasty, prevented early 
LAD systolic flow reversal indicative of severe dysfunction of the microcirculation, 
increased diastolic LAD velocities and flows but did not increase left ventricular systolic 
function. Understanding mechanisms of dysfunction of the coronary microcirculation and 
implementation of newer strategies to treat microcirculatory dysfunction with transthoracic 
Doppler evaluation may improve the treatment of patients with acute STEMI undergoing 
primary angioplasty.  
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